Parameters for successful monthly extended dosing of darbepoetin-alpha in patients undergoing hemodialysis.

Trachsler, J; Glück, Z; Dickenmann, M; Gauthier, T; Brünisholz, M; Martin, P-Y; Burnier, M; Wahl, C; Wüthrich, R P

Trachsler, J; Glück, Z; Dickenmann, M; Gauthier, T; Brünisholz, M; Martin, P-Y; Burnier, M; Wahl, C; Wüthrich, R P.

Affiliation

Trachsler J; Universitätsspital Zürich, Nephrologie, Zürich, Switzerland. johannes.trachsler@waid.zuerich.ch

Clin Nephrol ; 71(6): 697-702, 2009 Jun.

Article in En | MEDLINE | ID: mdl-19473639

Subject(s)

Anemia/prevention & control; Erythropoietin/analogs & derivatives; Hematinics/administration & dosage; Renal Dialysis/statistics & numerical data; Aged; Algorithms; Anemia/blood; Anemia/etiology; Darbepoetin alfa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring/methods; Erythropoietin/administration & dosage; Feasibility Studies; Female; Hemoglobins/analysis; Humans; Kidney Failure, Chronic/blood; Kidney Failure, Chronic/complications; Kidney Failure, Chronic/therapy; Male; Middle Aged; Prospective Studies; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Renal Dialysis / Hematinics / Anemia Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Nephrol Year: 2009 Type: Article Affiliation country: Switzerland

Search on Google

XML

PubMed Links